Genetics company 23andMe has raised $9 million to add to the $22 million Series C round that they announced this past November. MPM Capital and Johnson & Johnson Development Corporation participated in the $9 million financing. MPM Capital Managing Director Ashley Ledbetter will be joining 23andMe’s board of directors. 23andMe now has a total of $54 million in funding. [TechCrunch]

23andMe is a personal genetics company that was co-founded by the wife of Google co-founder Segrey Brin, Anne Wojcicki. The company has raised a $22 million third round of funding from Johnson & Johnson Development Corporation, New Enterprise Associates, and Google Ventures. 23andMe was founded in 2006 with the goal of helping people understand their genetics through DNA analysis technologies.

Beginning today, you’ll see an interview that Jill and I did for CBS. You can click here to play it. It’ll play this week all over local news stations.

Genetic testing company 23andMe has raised $28 million in Series B according to a company regulatory filing. The company raised $11 million of the Series B round of funding back in May and raised the rest of it recently.  The company initially planned to raised $24.26 million.  23andMe was founded by Anne Wojcicki and Linda Avey.  Avey recently quit the company but remained on the board of directors. 23andMe’s Series A round of funding was provided by Google, Genentech, Mohr Davidow Ventures (MDV), and New Enterprise Associates.  MDV sold their stake back to 23andMe and invested in another rival company called Navigenics.

There is a website called Blame Drew’s Cancer that focuses specifically on raising awareness of cancer.  The website aims to raise money for cancer  as well.  To raise the awareness, Blame Drew’s Cancer has Twitter users paste the hashtag #BlameDrewsCancer in their tweets.

Lance Armstrong’s LIVESTRONG foundation is already on board with Blame Drew’s Cancer and today 23andMe announced that they have joined the cause.  For every 500 unique tweets that adds the hashtag #BlameDrewsCancer and #23andMe, 23andMe will donate $1 to the cause.

23andMe will start donating after the hashtag #BlameDrewsCancer is used by the 10,000 person. 23andMe will be donating 5 of their $99 research kits to Blame Drew’s Cancer followers based on a raffle system.

[via TechCrunch]

Google has reported to the Securities and Exchange Commission that they have invested $2.6 million in the genetic testing startup 23andMe as part of a Series B round of funding.  23andMe was co-founded by Google co-founder Sergey Brin’s wife Anne Wojcicki.

It is uncertain whether the deal was made directly through Google or through their Ventures subsidiary.  The $2.6 million round of fund was part of a $12.6 million Series B round.  The other $10 million came from Sergey Brin’s personal wealth of $12 billion.  This brings 23andMe’s total funding to about $21.6 million.  Other investors include Genentech, New Enterprise Associates, and Mohr Davidow Ventures.

Google owns a minority interest in 23andMe and also plans to lease space to the genetics company.  Google wrote in the filing that they took measures to ensure the decision before investing to make the agreement was free of conflict of interest.  Sergey Brin was not part of the investment discussions according to Google CEO Eric Schmidt.

[via BusinessInsider/NYT]

23andMe is a personal genomics and biotech company based in Mountain View, California.  23andMe offers tests for genome-wide, single nucleotide polymorphisms for the cost of $299.  23andMe received $3.9 million investment from Google.  Google co-founder is married to 23andMe co-founder Anne Wojcicki.

Today it was announced that 23andMe raised an additional $11 million of a $24.26 million venture round according to a regulatory filing.  23andMe’s first round of funding was $9 million by Google, Genentech, New Enterprise Associates, and Mohr Davidow Ventures.

In this new round, there wasn’t any investor information mentioned.  No info on whether Google Ventures or Google.org was part of the investment.  23andMe’s website currently only lists New Enterprise Associates and Google as their investors.  If we find out who the investors are, we’ll update with a new post.